https://www.massgeneral.org/news/press-release/pi3k-inhibitors-breast-cancer
0
0
Researchers Identify the Mutations That Drive Resistance to PI3K Inhibitors in Breast Cancer That Can Be Overcome by Next Generation Agents - Massachusetts General Hospital
+ 98 more
11/2/23 at 2:19pm
Organization
Massgeneral.org
49 words
0
Comments
In patients with advanced breast cancers, Mass General Cancer Center researchers showed that a new class of PI3Kα inhibitors can overcome these resistance-generating mutations.
You are the first to view
Create an account or login to join the discussion